Enovis Corp (ENOV) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
44/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseENOV / S&P -9.01% / 15.20% |
LoseENOV / S&P 4.89% / 15.00% |
LoseENOV / S&P 29.33% / 50.40% |
| 2026-Q11/3 |
LoseENOV / S&P -14.60% / -4.33% |
LoseENOV / S&P 5.96% / 11.30% |
WinENOV / S&P 36.23% / 27.70% |
| 2025-Q41/3 |
LoseENOV / S&P -12.20% / 2.65% |
LoseENOV / S&P 6.66% / 9.00% |
WinENOV / S&P 38.69% / 13.40% |
| 2025-Q32/3 |
LoseENOV / S&P -3.25% / 8.12% |
WinENOV / S&P 11.57% / 4.61% |
WinENOV / S&P 1015.14% / 13.45% |
| 2025-Q22/3 |
LoseENOV / S&P -17.93% / 10.94% |
WinENOV / S&P 14.40% / 4.83% |
WinENOV / S&P 803.03% / 10.63% |
| 2025-Q12/3 |
LoseENOV / S&P -12.92% / -4.27% |
WinENOV / S&P 18.32% / 4.98% |
WinENOV / S&P 879.87% / 10.57% |
| 2024-Q42/3 |
LoseENOV / S&P 1.93% / 2.41% |
WinENOV / S&P 23.46% / 5.25% |
WinENOV / S&P 2390.00% / 6.15% |
| 2024-Q32/3 |
LoseENOV / S&P -4.76% / 5.89% |
WinENOV / S&P 20.52% / 5.89% |
WinENOV / S&P 59.12% / 6.11% |
| 2024-Q21/3 |
LoseENOV / S&P -27.62% / 4.28% |
WinENOV / S&P 17.62% / 5.38% |
LoseENOV / S&P -35.29% / 5.12% |
| 2024-Q13/3 |
WinENOV / S&P 11.48% / 10.56% |
WinENOV / S&P 14.02% / 5.71% |
WinENOV / S&P 55.21% / 5.59% |
| 2023-Q42/3 |
LoseENOV / S&P 6.24% / 11.69% |
WinENOV / S&P 9.22% / 6.81% |
WinENOV / S&P 140.00% / 7.78% |
| 2023-Q30/3 |
LoseENOV / S&P -17.76% / -3.27% |
LoseENOV / S&P 6.92% / 7.52% |
LoseENOV / S&P -442.50% / -5.03% |
| 2023-Q21/3 |
WinENOV / S&P 19.87% / 8.74% |
LoseENOV / S&P 6.38% / 9.50% |
LoseENOV / S&P -220.28% / -8.57% |
| 2023-Q10/3 |
LoseENOV / S&P -0.06% / 7.50% |
LoseENOV / S&P 6.93% / 10.77% |
LoseENOV / S&P -175.59% / -15.69% |
| 2022-Q41/3 |
WinENOV / S&P 16.17% / 7.56% |
LoseENOV / S&P -21.62% / 11.88% |
LoseENOV / S&P -117.99% / -17.99% |
| 2022-Q31/3 |
LoseENOV / S&P -16.24% / -4.88% |
WinENOV / S&P 228.21% / 13.47% |
LoseENOV / S&P -82.68% / -1.41% |
| 2022-Q21/3 |
LoseENOV / S&P -19.69% / -16.10% |
WinENOV / S&P 66.38% / 13.71% |
LoseENOV / S&P 10.42% / 11.04% |
| 2022-Q11/3 |
LoseENOV / S&P -13.44% / -4.60% |
WinENOV / S&P 25.94% / 15.97% |
LoseENOV / S&P -2.31% / 42.23% |
| 2021-Q41/3 |
LoseENOV / S&P 0.15% / 11.03% |
WinENOV / S&P 77.95% / 15.00% |
LoseENOV / S&P 49.46% / 96.40% |
| 2021-Q30/3 |
LoseENOV / S&P 0.20% / 0.58% |
LoseENOV / S&P -84.88% / 10.77% |
LoseENOV / S&P -4720.00% / 69.42% |
| 2021-Q20/3 |
LoseENOV / S&P 4.57% / 8.55% |
LoseENOV / S&P -71.01% / 6.58% |
LoseENOV / S&P -2842.86% / 51.81% |
| 2021-Q11/3 |
WinENOV / S&P 14.57% / 6.17% |
LoseENOV / S&P -65.79% / -1.06% |
LoseENOV / S&P -137.57% / 7.39% |
| 2020-Q41/3 |
WinENOV / S&P 21.94% / 12.15% |
LoseENOV / S&P -66.32% / -3.72% |
LoseENOV / S&P -123.97% / -33.42% |
| 2020-Q32/3 |
WinENOV / S&P 12.40% / 8.93% |
WinENOV / S&P 3.88% / -2.04% |
LoseENOV / S&P -98.52% / -27.10% |
| 2020-Q22/3 |
WinENOV / S&P 40.91% / 20.54% |
WinENOV / S&P 17.84% / -0.46% |
LoseENOV / S&P -97.81% / -27.11% |
| 2020-Q11/3 |
LoseENOV / S&P -45.57% / -19.60% |
WinENOV / S&P 47.62% / 3.47% |
LoseENOV / S&P -707.02% / -14.75% |
| 2019-Q42/3 |
WinENOV / S&P 25.19% / 9.07% |
WinENOV / S&P 30.96% / 5.36% |
LoseENOV / S&P ENOV unavailable / 2.99% |
| 2019-Q32/3 |
WinENOV / S&P 3.67% / 1.70% |
WinENOV / S&P 104.07% / 5.02% |
LoseENOV / S&P ENOV unavailable / 0.21% |
| 2019-Q21/3 |
LoseENOV / S&P -5.56% / 4.30% |
WinENOV / S&P 49.74% / 6.64% |
LoseENOV / S&P ENOV unavailable / 8.65% |
| 2019-Q12/3 |
WinENOV / S&P 42.01% / 13.65% |
WinENOV / S&P 12.43% / 8.12% |
LoseENOV / S&P ENOV unavailable / 14.29% |
| 2018-Q41/3 |
LoseENOV / S&P -42.04% / -13.52% |
WinENOV / S&P 31.15% / 9.05% |
LoseENOV / S&P ENOV unavailable / 18.23% |
| 2018-Q31/3 |
WinENOV / S&P 17.65% / 7.71% |
LoseENOV / S&P -54.39% / 10.21% |
LoseENOV / S&P ENOV unavailable / 19.06% |
| 2018-Q20/3 |
LoseENOV / S&P -3.92% / 3.43% |
LoseENOV / S&P -43.13% / 9.03% |
LoseENOV / S&P ENOV unavailable / 14.46% |
| 2018-Q10/3 |
LoseENOV / S&P -19.49% / -0.76% |
LoseENOV / S&P -36.25% / 7.68% |
LoseENOV / S&P ENOV unavailable / 12.46% |
| 2017-Q40/3 |
LoseENOV / S&P -4.85% / 6.64% |
LoseENOV / S&P -43.24% / 7.03% |
LoseENOV / S&P ENOV unavailable / 13.82% |
| 2017-Q31/3 |
WinENOV / S&P 5.77% / 4.48% |
LoseENOV / S&P 3.49% / 5.68% |
LoseENOV / S&P ENOV unavailable / 17.57% |
| 2017-Q20/3 |
LoseENOV / S&P 0.28% / 3.09% |
LoseENOV / S&P -5.15% / 4.83% |
LoseENOV / S&P ENOV unavailable / 17.74% |
| 2017-Q11/3 |
WinENOV / S&P 9.27% / 6.07% |
LoseENOV / S&P -3.83% / 3.67% |
LoseENOV / S&P ENOV unavailable / 13.32% |
| 2016-Q41/3 |
WinENOV / S&P 14.32% / 3.82% |
LoseENOV / S&P -0.62% / 2.09% |
LoseENOV / S&P ENOV unavailable / 7.05% |
| 2016-Q31/3 |
WinENOV / S&P 18.78% / 3.85% |
LoseENOV / S&P -23.90% / 0.20% |
LoseENOV / S&P ENOV unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | ENOV total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -19.64% | 20.78% |
| Annualized return | -19.64% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | ENOV total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -70.21% | 83.14% |
| Annualized return | -21.51% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | ENOV total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -50.81% | 319.30% |
| Annualized return | -6.85% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |